SVSO — SheerVision Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.09m
- $3.50m
Annual income statement for SheerVision, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2007 August 31st | C2008 August 31st | 2009 August 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 4.35 | 4.42 | 3.5 |
| Cost of Revenue | |||
| Gross Profit | 2.92 | 2.75 | 2.18 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 5.27 | 4.64 | 3.67 |
| Operating Profit | -0.915 | -0.221 | -0.172 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -0.902 | -0.223 | -0.072 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.905 | -0.223 | -0.072 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0.905 | -0.223 | -0.072 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Dilution Adjustment | |||
| Diluted Net Income | -1.17 | -0.464 | -0.312 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.095 | -0.036 | -0.023 |
| Dividends per Share |